logo
* 搜尋
* 核能資訊中心
* 中心簡介
* 日本福島核災專區
* 相關資訊
國際核能現況 : Bruce Power and ITM to supply cancer therapy isotope
發表人 nicenter 於 2018/7/2 10:40:05 (17 人讀取)

Bruce Power and ITM to supply cancer therapy isotope


Bruce Power and ITG, a subsidiary of radiopharmaceutical technology company ITM Isotopen Technologien München (ITM), have launched a joint effort to explore the production of the medical radioisotope lutetium-177 (Lu-177) at Bruce Power's Candu reactors.



Bruce-ITM_Lu-177_MOU_June18_(Bruce)-460

ITM's Mark Harfensteller, seated at left, signs the MoU with Bruce's James Scongack, front centre. Also shown are Bruce Power's Pat Dalzell at front right, with ITM's Ingo Russnak and Bruce Power's Kurt Wigle standing. (Image: Bruce Power)


Lu-177 is used in targeted radionuclide therapy to treat cancers like neuroendocrine tumours and prostate cancer. The medical-grade radioisotope is used to destroy cancer cells while leaving healthy cells unaffected.


The companies yesterday announced the signature of a Memorandum of Understanding to explore the production of Lu-177 at Bruce, which they say has the ability to meet global supply needs until 2064. The partnership aims to meet the medical community's growing demand for the radioisotope. Development, processing, and global distribution of Lu-177 will be managed by ITG.


Bruce's Candu units already produce cobalt-60, which is used for the sterilisation of medical equipment and in a specialised form of cancer treatment called the Gamma Knife. The company is part of the recently established Canadian Nuclear Isotope Council, which aims to develop collective solutions to maintain Canada's leadership position on the global isotope stage following the shut-down earlier this year of the National Research Universal reactor after over 60 years of operation.


Bruce Power in 2017 signed an agreement with Areva NP - now Orano - for Areva to design and supply equipment to be installed in the existing Bruce Candu units to add online production at commercial scale of a wide range of isotopes including short half-life isotopes such as Mo-99, Lu-177 and iridium-192 using a system that inserts and removes targets with little impact on the normal operation of the power reactors.


"Bruce Power is a world leader in the production of critical radioisotopes used to treat cancer," said Mike Rencheck, Bruce Power's president and CEO. "By developing innovative ways to generate these radioisotopes, we help ensure that the medical community has access to a reliable source of medical radioisotopes for Targeted Radionuclide Therapy."


Steffen Schuster, CEO of ITM, said: "With Bruce Power's long-term outlook to operate its facility through 2064 and its existing expertise with cobalt production, we have the opportunity to provide a stable source of lutetium-177 to cancer patients worldwide."


Researched and written
by World Nuclear News



source: http://www.world-nuclear-news.org/RS-Bruce-Power-and-ITM-to-supply-cancer-therapy-isotope-2906187.html



其他新聞
2018/7/16 10:00:56 - WANO completes reviews of Leningrad and Tianwan plants
2018/7/16 9:57:23 - Yangjiang 5 enters commercial operation
2018/7/16 9:46:00 - ‘Breakthrough’ For Bulgaria As €31M Plasma Melting Plant Begins Operations At Kozloduy Nuclear Station
2018/7/16 9:43:19 - European Court Dismisses Austria’s Objections To Hinkley Point C
2018/7/13 10:22:08 - Austrian case against Hinkley Point C aid rejected
2018/7/13 10:19:37 - UK's post-Brexit nuclear plans face scrutiny
2018/7/13 10:13:34 - 輻射監測生力軍!石門水庫、清華大學環境輻射監測站正式上線
2018/7/13 10:06:30 - 核三廠1號機預定於7月15日降載例行測試,原能會持續監控電廠運轉安全
2018/7/9 10:51:40 - Think-tanks call for states to adopt Clean Energy Standards
2018/7/9 10:49:29 - EDF maintains plant safety is a priority
2018/7/9 10:47:06 - NEI issues guidelines for regulatory interactions
2018/7/6 12:09:34 - 核二廠2號機於今(6)日降載進行例行測試,原能會持續監控電廠運轉安全(更新)
2018/7/6 12:08:15 - 核二廠2號機預定於7月7日降載例行測試,原能會持續監控電廠運轉安全
2018/7/4 10:08:53 - Boss launches Honeymoon restart strategy
2018/7/4 10:04:16 - NDA to take over management of Magnox sites
2018/7/4 9:58:23 - Japanese Cabinet approves new basic energy plan
2018/7/4 9:50:06 - 今(04)日04時10分台東縣政府北方規模4.6有感地震,各核能電廠皆正常運作,原能會持續監控電廠運轉安全
2018/7/4 9:42:18 - 核二廠1號機反應器圍阻體廠房氣體流程輻射監測器發出警戒訊號之說明
2018/7/2 10:44:58 - China's Taishan 1 reactor connected to grid
2018/7/2 10:40:05 - Bruce Power and ITM to supply cancer therapy isotope

 線上期刊目錄

 瀏覽人數
今天: 142
昨天: 122
本月: 2466
總計: 530693

30013 新竹市光復路二段101號 創新育成中心三樓309室 電話:(03)571-1808 傳真:(03)572-5461 Email: nicenter@nicenter.org.tw